Expanding the phenotype of SCA19/22: Parkinsonism, cognitive impairment and epilepsy

Spinocerebellar ataxia types 19 and 22 (SCA19/22) are rare conditions in which relatively isolated cerebellar involvement is frequently associated with cognitive impairment. Here, we report on new clinical features and provide details of the cognitive profile in two SCA19/22 families. Two families d...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Parkinsonism & related disorders 2017-12, Vol.45, p.85-89
Hauptverfasser: Huin, Vincent, Strubi-Vuillaume, Isabelle, Dujardin, Kathy, Brion, Marine, Delliaux, Marie, Dellacherie, Delphine, Cuvellier, Jean-Christophe, Cuisset, Jean-Marie, Riquet, Audrey, Moreau, Caroline, Defebvre, Luc, Sablonnière, Bernard, Devos, David
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 89
container_issue
container_start_page 85
container_title Parkinsonism & related disorders
container_volume 45
creator Huin, Vincent
Strubi-Vuillaume, Isabelle
Dujardin, Kathy
Brion, Marine
Delliaux, Marie
Dellacherie, Delphine
Cuvellier, Jean-Christophe
Cuisset, Jean-Marie
Riquet, Audrey
Moreau, Caroline
Defebvre, Luc
Sablonnière, Bernard
Devos, David
description Spinocerebellar ataxia types 19 and 22 (SCA19/22) are rare conditions in which relatively isolated cerebellar involvement is frequently associated with cognitive impairment. Here, we report on new clinical features and provide details of the cognitive profile in two SCA19/22 families. Two families displaying an autosomal-dominant form of cerebellar ataxia underwent clinical examinations and genetic testing. In addition to the classical clinical features of SCA, a wide spectrum of cognitive disorders (including visuospatial impairments) was observed. Eight patients had mild Parkinsonism, and five had epilepsy. Genetic testing showed that the KCND3 mutation (c.679_681delTTC, p.F227del) was present in both families. Our findings broaden the phenotypic spectrum of SCA19/22, and suggest that KCND3 should be included in the list of candidate genes for epilepsy, Parkinsonism and cognitive impairment. •SCA19 and SCA22 (caused by KCND3 gene mutations) are rare forms of inherited ataxia.•We observed Parkinsonism is a high proportion of individuals with SCA19/22.•Epilepsy seems to be a feature of SCA19/22.•We characterized cognitive and behavioral disorders.•KCND3 may be a candidate gene for epilepsy, Parkinsonism and cognitive disorders.
doi_str_mv 10.1016/j.parkreldis.2017.09.014
format Article
fullrecord <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_02467104v2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1353802017303437</els_id><sourcerecordid>1943284879</sourcerecordid><originalsourceid>FETCH-LOGICAL-c524t-48e0f5bd10652d5427c76f9e88f63c3ca6f3b3cf5afe2bdac29e219fa76d49513</originalsourceid><addsrcrecordid>eNqFkE1vEzEQhi0EoqXwF5CPILFbf67X3NKo0EqRqNRythzvuHHYtRd7E5F_z0Yp5djTjEbPvK_0IIQpqSmhzeW2Hm3-laHvQqkZoaomuiZUvELntFW8kpQ1r-edS161hJEz9K6ULSFEScLfojPWaqGI4ufo4frPaGMX4iOeNoDHDcQ0HUbAyeP75YLqS8a-4ru5LcSSYijDF-zSYwxT2AMOw2hDHiBOeA7BMIYexnJ4j9542xf48DQv0M9v1w_Lm2r14_vtcrGqnGRiqkQLxMt1R0kjWScFU041XkPb-oY77mzj-Zo7L60Htu6sYxoY1d6qphNaUn6BPp9yN7Y3Yw6DzQeTbDA3i5U53ggTjaJE7NnMfjqxY06_d1AmM4TioO9thLQrhmrBWStapWe0PaEup1Iy-OdsSszRv9ma__7N0b8h2sz-59ePTy279QDd8-M_4TNwdQJg9rIPkE1xAaKDLmRwk-lSeLnlL7otmzA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1943284879</pqid></control><display><type>article</type><title>Expanding the phenotype of SCA19/22: Parkinsonism, cognitive impairment and epilepsy</title><source>Elsevier ScienceDirect Journals</source><creator>Huin, Vincent ; Strubi-Vuillaume, Isabelle ; Dujardin, Kathy ; Brion, Marine ; Delliaux, Marie ; Dellacherie, Delphine ; Cuvellier, Jean-Christophe ; Cuisset, Jean-Marie ; Riquet, Audrey ; Moreau, Caroline ; Defebvre, Luc ; Sablonnière, Bernard ; Devos, David</creator><creatorcontrib>Huin, Vincent ; Strubi-Vuillaume, Isabelle ; Dujardin, Kathy ; Brion, Marine ; Delliaux, Marie ; Dellacherie, Delphine ; Cuvellier, Jean-Christophe ; Cuisset, Jean-Marie ; Riquet, Audrey ; Moreau, Caroline ; Defebvre, Luc ; Sablonnière, Bernard ; Devos, David</creatorcontrib><description>Spinocerebellar ataxia types 19 and 22 (SCA19/22) are rare conditions in which relatively isolated cerebellar involvement is frequently associated with cognitive impairment. Here, we report on new clinical features and provide details of the cognitive profile in two SCA19/22 families. Two families displaying an autosomal-dominant form of cerebellar ataxia underwent clinical examinations and genetic testing. In addition to the classical clinical features of SCA, a wide spectrum of cognitive disorders (including visuospatial impairments) was observed. Eight patients had mild Parkinsonism, and five had epilepsy. Genetic testing showed that the KCND3 mutation (c.679_681delTTC, p.F227del) was present in both families. Our findings broaden the phenotypic spectrum of SCA19/22, and suggest that KCND3 should be included in the list of candidate genes for epilepsy, Parkinsonism and cognitive impairment. •SCA19 and SCA22 (caused by KCND3 gene mutations) are rare forms of inherited ataxia.•We observed Parkinsonism is a high proportion of individuals with SCA19/22.•Epilepsy seems to be a feature of SCA19/22.•We characterized cognitive and behavioral disorders.•KCND3 may be a candidate gene for epilepsy, Parkinsonism and cognitive disorders.</description><identifier>ISSN: 1353-8020</identifier><identifier>EISSN: 1873-5126</identifier><identifier>DOI: 10.1016/j.parkreldis.2017.09.014</identifier><identifier>PMID: 28947073</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Biochemistry, Molecular Biology ; Cognitive disorders ; Cognitive science ; Epilepsy ; Genetics ; Genomics ; Human genetics ; Human health and pathology ; KCND3 mutation ; Life Sciences ; Molecular biology ; Neurogenetics ; Neurons and Cognition ; Neuropsychiatric disorder ; Parkinson's disease ; Spinocerebellar ataxia</subject><ispartof>Parkinsonism &amp; related disorders, 2017-12, Vol.45, p.85-89</ispartof><rights>2017 Elsevier Ltd</rights><rights>Copyright © 2017 Elsevier Ltd. All rights reserved.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c524t-48e0f5bd10652d5427c76f9e88f63c3ca6f3b3cf5afe2bdac29e219fa76d49513</citedby><cites>FETCH-LOGICAL-c524t-48e0f5bd10652d5427c76f9e88f63c3ca6f3b3cf5afe2bdac29e219fa76d49513</cites><orcidid>0000-0001-8201-5406 ; 0000-0002-5503-4078 ; 0000-0002-2417-799X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1353802017303437$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28947073$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.univ-lille.fr/hal-02467104$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Huin, Vincent</creatorcontrib><creatorcontrib>Strubi-Vuillaume, Isabelle</creatorcontrib><creatorcontrib>Dujardin, Kathy</creatorcontrib><creatorcontrib>Brion, Marine</creatorcontrib><creatorcontrib>Delliaux, Marie</creatorcontrib><creatorcontrib>Dellacherie, Delphine</creatorcontrib><creatorcontrib>Cuvellier, Jean-Christophe</creatorcontrib><creatorcontrib>Cuisset, Jean-Marie</creatorcontrib><creatorcontrib>Riquet, Audrey</creatorcontrib><creatorcontrib>Moreau, Caroline</creatorcontrib><creatorcontrib>Defebvre, Luc</creatorcontrib><creatorcontrib>Sablonnière, Bernard</creatorcontrib><creatorcontrib>Devos, David</creatorcontrib><title>Expanding the phenotype of SCA19/22: Parkinsonism, cognitive impairment and epilepsy</title><title>Parkinsonism &amp; related disorders</title><addtitle>Parkinsonism Relat Disord</addtitle><description>Spinocerebellar ataxia types 19 and 22 (SCA19/22) are rare conditions in which relatively isolated cerebellar involvement is frequently associated with cognitive impairment. Here, we report on new clinical features and provide details of the cognitive profile in two SCA19/22 families. Two families displaying an autosomal-dominant form of cerebellar ataxia underwent clinical examinations and genetic testing. In addition to the classical clinical features of SCA, a wide spectrum of cognitive disorders (including visuospatial impairments) was observed. Eight patients had mild Parkinsonism, and five had epilepsy. Genetic testing showed that the KCND3 mutation (c.679_681delTTC, p.F227del) was present in both families. Our findings broaden the phenotypic spectrum of SCA19/22, and suggest that KCND3 should be included in the list of candidate genes for epilepsy, Parkinsonism and cognitive impairment. •SCA19 and SCA22 (caused by KCND3 gene mutations) are rare forms of inherited ataxia.•We observed Parkinsonism is a high proportion of individuals with SCA19/22.•Epilepsy seems to be a feature of SCA19/22.•We characterized cognitive and behavioral disorders.•KCND3 may be a candidate gene for epilepsy, Parkinsonism and cognitive disorders.</description><subject>Biochemistry, Molecular Biology</subject><subject>Cognitive disorders</subject><subject>Cognitive science</subject><subject>Epilepsy</subject><subject>Genetics</subject><subject>Genomics</subject><subject>Human genetics</subject><subject>Human health and pathology</subject><subject>KCND3 mutation</subject><subject>Life Sciences</subject><subject>Molecular biology</subject><subject>Neurogenetics</subject><subject>Neurons and Cognition</subject><subject>Neuropsychiatric disorder</subject><subject>Parkinson's disease</subject><subject>Spinocerebellar ataxia</subject><issn>1353-8020</issn><issn>1873-5126</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNqFkE1vEzEQhi0EoqXwF5CPILFbf67X3NKo0EqRqNRythzvuHHYtRd7E5F_z0Yp5djTjEbPvK_0IIQpqSmhzeW2Hm3-laHvQqkZoaomuiZUvELntFW8kpQ1r-edS161hJEz9K6ULSFEScLfojPWaqGI4ufo4frPaGMX4iOeNoDHDcQ0HUbAyeP75YLqS8a-4ru5LcSSYijDF-zSYwxT2AMOw2hDHiBOeA7BMIYexnJ4j9542xf48DQv0M9v1w_Lm2r14_vtcrGqnGRiqkQLxMt1R0kjWScFU041XkPb-oY77mzj-Zo7L60Htu6sYxoY1d6qphNaUn6BPp9yN7Y3Yw6DzQeTbDA3i5U53ggTjaJE7NnMfjqxY06_d1AmM4TioO9thLQrhmrBWStapWe0PaEup1Iy-OdsSszRv9ma__7N0b8h2sz-59ePTy279QDd8-M_4TNwdQJg9rIPkE1xAaKDLmRwk-lSeLnlL7otmzA</recordid><startdate>201712</startdate><enddate>201712</enddate><creator>Huin, Vincent</creator><creator>Strubi-Vuillaume, Isabelle</creator><creator>Dujardin, Kathy</creator><creator>Brion, Marine</creator><creator>Delliaux, Marie</creator><creator>Dellacherie, Delphine</creator><creator>Cuvellier, Jean-Christophe</creator><creator>Cuisset, Jean-Marie</creator><creator>Riquet, Audrey</creator><creator>Moreau, Caroline</creator><creator>Defebvre, Luc</creator><creator>Sablonnière, Bernard</creator><creator>Devos, David</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>1XC</scope><scope>VOOES</scope><orcidid>https://orcid.org/0000-0001-8201-5406</orcidid><orcidid>https://orcid.org/0000-0002-5503-4078</orcidid><orcidid>https://orcid.org/0000-0002-2417-799X</orcidid></search><sort><creationdate>201712</creationdate><title>Expanding the phenotype of SCA19/22: Parkinsonism, cognitive impairment and epilepsy</title><author>Huin, Vincent ; Strubi-Vuillaume, Isabelle ; Dujardin, Kathy ; Brion, Marine ; Delliaux, Marie ; Dellacherie, Delphine ; Cuvellier, Jean-Christophe ; Cuisset, Jean-Marie ; Riquet, Audrey ; Moreau, Caroline ; Defebvre, Luc ; Sablonnière, Bernard ; Devos, David</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c524t-48e0f5bd10652d5427c76f9e88f63c3ca6f3b3cf5afe2bdac29e219fa76d49513</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Biochemistry, Molecular Biology</topic><topic>Cognitive disorders</topic><topic>Cognitive science</topic><topic>Epilepsy</topic><topic>Genetics</topic><topic>Genomics</topic><topic>Human genetics</topic><topic>Human health and pathology</topic><topic>KCND3 mutation</topic><topic>Life Sciences</topic><topic>Molecular biology</topic><topic>Neurogenetics</topic><topic>Neurons and Cognition</topic><topic>Neuropsychiatric disorder</topic><topic>Parkinson's disease</topic><topic>Spinocerebellar ataxia</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Huin, Vincent</creatorcontrib><creatorcontrib>Strubi-Vuillaume, Isabelle</creatorcontrib><creatorcontrib>Dujardin, Kathy</creatorcontrib><creatorcontrib>Brion, Marine</creatorcontrib><creatorcontrib>Delliaux, Marie</creatorcontrib><creatorcontrib>Dellacherie, Delphine</creatorcontrib><creatorcontrib>Cuvellier, Jean-Christophe</creatorcontrib><creatorcontrib>Cuisset, Jean-Marie</creatorcontrib><creatorcontrib>Riquet, Audrey</creatorcontrib><creatorcontrib>Moreau, Caroline</creatorcontrib><creatorcontrib>Defebvre, Luc</creatorcontrib><creatorcontrib>Sablonnière, Bernard</creatorcontrib><creatorcontrib>Devos, David</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><jtitle>Parkinsonism &amp; related disorders</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Huin, Vincent</au><au>Strubi-Vuillaume, Isabelle</au><au>Dujardin, Kathy</au><au>Brion, Marine</au><au>Delliaux, Marie</au><au>Dellacherie, Delphine</au><au>Cuvellier, Jean-Christophe</au><au>Cuisset, Jean-Marie</au><au>Riquet, Audrey</au><au>Moreau, Caroline</au><au>Defebvre, Luc</au><au>Sablonnière, Bernard</au><au>Devos, David</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Expanding the phenotype of SCA19/22: Parkinsonism, cognitive impairment and epilepsy</atitle><jtitle>Parkinsonism &amp; related disorders</jtitle><addtitle>Parkinsonism Relat Disord</addtitle><date>2017-12</date><risdate>2017</risdate><volume>45</volume><spage>85</spage><epage>89</epage><pages>85-89</pages><issn>1353-8020</issn><eissn>1873-5126</eissn><abstract>Spinocerebellar ataxia types 19 and 22 (SCA19/22) are rare conditions in which relatively isolated cerebellar involvement is frequently associated with cognitive impairment. Here, we report on new clinical features and provide details of the cognitive profile in two SCA19/22 families. Two families displaying an autosomal-dominant form of cerebellar ataxia underwent clinical examinations and genetic testing. In addition to the classical clinical features of SCA, a wide spectrum of cognitive disorders (including visuospatial impairments) was observed. Eight patients had mild Parkinsonism, and five had epilepsy. Genetic testing showed that the KCND3 mutation (c.679_681delTTC, p.F227del) was present in both families. Our findings broaden the phenotypic spectrum of SCA19/22, and suggest that KCND3 should be included in the list of candidate genes for epilepsy, Parkinsonism and cognitive impairment. •SCA19 and SCA22 (caused by KCND3 gene mutations) are rare forms of inherited ataxia.•We observed Parkinsonism is a high proportion of individuals with SCA19/22.•Epilepsy seems to be a feature of SCA19/22.•We characterized cognitive and behavioral disorders.•KCND3 may be a candidate gene for epilepsy, Parkinsonism and cognitive disorders.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>28947073</pmid><doi>10.1016/j.parkreldis.2017.09.014</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0001-8201-5406</orcidid><orcidid>https://orcid.org/0000-0002-5503-4078</orcidid><orcidid>https://orcid.org/0000-0002-2417-799X</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1353-8020
ispartof Parkinsonism & related disorders, 2017-12, Vol.45, p.85-89
issn 1353-8020
1873-5126
language eng
recordid cdi_hal_primary_oai_HAL_hal_02467104v2
source Elsevier ScienceDirect Journals
subjects Biochemistry, Molecular Biology
Cognitive disorders
Cognitive science
Epilepsy
Genetics
Genomics
Human genetics
Human health and pathology
KCND3 mutation
Life Sciences
Molecular biology
Neurogenetics
Neurons and Cognition
Neuropsychiatric disorder
Parkinson's disease
Spinocerebellar ataxia
title Expanding the phenotype of SCA19/22: Parkinsonism, cognitive impairment and epilepsy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T08%3A24%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Expanding%20the%20phenotype%20of%20SCA19/22:%20Parkinsonism,%20cognitive%20impairment%20and%20epilepsy&rft.jtitle=Parkinsonism%20&%20related%20disorders&rft.au=Huin,%20Vincent&rft.date=2017-12&rft.volume=45&rft.spage=85&rft.epage=89&rft.pages=85-89&rft.issn=1353-8020&rft.eissn=1873-5126&rft_id=info:doi/10.1016/j.parkreldis.2017.09.014&rft_dat=%3Cproquest_hal_p%3E1943284879%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1943284879&rft_id=info:pmid/28947073&rft_els_id=S1353802017303437&rfr_iscdi=true